Acorn Bioventures is a Venture Capital Fund in New York with $314.90 mm assets under management, with a minimum investment of $1.00 mm. It has 18 beneficial owners. Data from SEC filing.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$314.90 mm
Address
Acorn Bioventures
295 MADISON AVENUE
32ND FL
NEW YORK
NY 10017
295 MADISON AVENUE
32ND FL
NEW YORK
NY 10017
Phone
917-940-2732
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Acorn Capital Advisors, LLC | $314.90 mm | |
Acorn Bioventures 2, L.P. | Venture Capital Fund | |
Acorn Bioventures, L.P. | $314.90 mm | Venture Capital Fund |
Latest filings (excl ownership)
Latest ownership filings
SC 13D
Q32 Bio Inc.
4 Apr 24
SC 13G
X4 Pharmaceuticals, Inc
14 Feb 24
SC 13G/A
OptiNose, Inc.
13 Feb 24
SC 13G/A
Cyclacel Pharmaceuticals, Inc.
7 Feb 24
SC 13G/A
Cardiff Oncology, Inc.
6 Feb 24
SC 13G/A
Y-mAbs Therapeutics, Inc.
6 Feb 24
SC 13G/A
BioAtla, Inc.
6 Feb 24
SC 13G/A
PUMA BIOTECHNOLOGY, INC.
6 Feb 24
SC 13G
PUMA BIOTECHNOLOGY, INC.
1 Sep 23
SC 13G
BioAtla, Inc.
27 Apr 23